Close
  Indian J Med Microbiol
 

Figure 2: (a) Serum α-L-fucosidase, α-2,3 and α-2,6 sialyltransferase and sialidase in PT, complete responder and nonresponders patients. The values are expressed as mean ± standard error of mean in mU/mg protein PTc: Pretreatment levels of CR, PTn: Pretreatment levels of nonresponders. (b) Salivary α-L-fucosidase, α-2,3 and α-2,6 sialyltransferase and sialidase in pretreatment, complete responder and nonresponders patients. The values are expressed as mean ± standard error of mean in mu/mg protein PTc: Pretreatment levels of CR, PTn: Pretreatment levels of nonresponders

Figure 2: (a) Serum α-L-fucosidase, α-2,3 and α-2,6 sialyltransferase and sialidase in PT, complete responder and nonresponders patients. The values are expressed as mean ± standard error of mean in mU/mg protein PTc: Pretreatment levels of CR, PTn: Pretreatment levels of nonresponders. (b) Salivary α-L-fucosidase, α-2,3 and α-2,6 sialyltransferase and sialidase in pretreatment, complete responder and nonresponders patients. The values are expressed as mean ± standard error of mean in mu/mg protein PTc: Pretreatment levels of CR, PTn: Pretreatment levels of nonresponders